- Home
- MBIO
MBIO
Mustang Bio Inc.
as 12-27-2024 1:37pm EST
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | WORCESTER |
| Market Cap: | 9.1M | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 671.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.13 - $1.53 | Next Earning Date: | 11-08-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Mustang Bio Inc. News
MBIO Breaking Stock News: Dive into MBIO Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Mustang Bio Receives Positive Listing Determination from Nasdaq
Pharmaceutical Technology
2 months ago
Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment
MT Newswires
2 months ago
Mustang Bio Gets FDA Orphan Drug Designation for MB-108 in Malignant Glioma Treatment
GlobeNewswire
2 months ago
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
TipRanks
2 months ago
Mustang Bio Secures $4M through Strategic Warrant Agreement
GlobeNewswire
2 months ago
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
GlobeNewswire
6 months ago
Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)
GlobeNewswire
6 months ago
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Compare MBIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MBIO Mustang Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.